In the present study, the AFP, AFP-L3 and DCP levels in HCC patients decreased sharply after treatment, whereas the GP73 level increased immediately after treatment and then returned to the baseline level one month after treatment. The gene discussed is AFP; the disease is hepatocellular carcinoma.